B. Dharan

Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancer.

F. Shepherd, R. Ramlau, M. Krzakowski, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER 2-Positive Breast Cancer

R. Greil, E. Winer, Minetta C. Liu, 2009 .

Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.

H. Deeg, Richard E. Harris, N. Ramsay, 2002, Blood.

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

R. Greil, E. Winer, Minetta C. Liu, 2009, Clinical Cancer Research.

Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors

J. Wingard, K. Ballen, M. Popovsky, 2002, Transfusion.

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Oral topotecan demonstrates clinical activity in relapsed non-small cell lung cancer. Results from an open-label, phase III study (387) comparing oral topotecan to intravenous docetaxel

F. Shepherd, R. Ramlau, M. Krzakowski, 2005 .

1194MO Canakinumab (CAN) + docetaxel (DTX) for the second- or third-line (2/3L) treatment of advanced non-small cell lung cancer (NSCLC): CANOPY-2 phase III results

B. Halmos, L. Paz-Ares, B. Cho, 2021, Annals of Oncology.